Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 4/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | ACLY | P53396 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22156895 | 0.97 | CYP11B1 (0.40) | CYP11B1CYP11B2CNR2FLT3ACLY | |
| SCHEMBL22157151 | 0.93 | CYP11B1 (0.38) | CYP11B1CYP11B2CNR2FLT3ACLY | |
| SCHEMBL22156894 | 0.92 | CYP11B1 (0.35) | CYP11B1CYP11B2CNR2MAP4K1NR3C1 | |
| SCHEMBL22156559 | 0.91 | CYP11B1 (0.39) | CYP11B1CYP11B2CNR2FLT3ACLY | |
| SCHEMBL22158523 | 0.91 | CYP11B1 (0.42) | CYP11B1CYP11B2CNR2MAP4K1NR3C1 | |
| SCHEMBL22156577 | 0.90 | CYP11B1 (0.36) | CYP11B1CYP11B2CNR2FLT3ACLY | |
| SCHEMBL22155951 | 0.89 | CYP11B1 (0.35) | CYP11B1CYP11B2CNR2FLT3 | |
| SCHEMBL22156573 | 0.89 | SLC6A9 (0.38) | CYP11B1CYP11B2FLT3MAP4K1NR3C1 | |
| SCHEMBL20437450 | 0.88 | TSPO (0.38) | CYP11B1CYP11B2TSPOESR1ESR2 | |
| SCHEMBL22157140 | 0.88 | CYP11B1 (0.36) | CYP11B1CYP11B2CNR2MAP4K1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | CYP11B1 827/4885CYP11B2 531/4885CNR2 1715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.